On February 06, 2025, Sun Pharma shares to trade ex-date, meaning that the shareholders registered in the company’s books will be eligible for the ₹10.50 interim dividend.
| Ex-Date | Dividend Type | Dividend Amount (₹) |
| July 12, 2024 | Final | 5.00 |
| Feb 09, 2024 | Interim | 8.50 |
| July 28, 2023 | Final | 4.00 |
India Formulations: India’s formulation sales reached ₹43,004 million, reflecting a 13.8% growth compared to the same period last year, accounting for approximately 32% of total consolidated sales. For the first nine months, sales stood at ₹127,100 million, growing by 13.7%. Sun Pharma maintains its leadership as the No. 1 ranked company in the Indian pharmaceutical market, with a market share increase from 7.8% to 8.2%, according to the AIOCD AWACS MAT Dec-2024 report.
US Formulations: In the US, formulation sales were US$ 474 million in Q3FY25, a slight decrease of 0.7% year-on-year, contributing around 30% to the total consolidated sales. Over the first nine months, sales totalled US$ 1,457 million, marking a 5.7% growth. Sales in Emerging Markets (EM) reached US$ 277 million in Q3FY25, up by 10.1% compared to Q3 last year and accounting for 17% of consolidated sales.
API: External sales of Active Pharmaceutical Ingredients (API) in Q3FY25 amounted to ₹5,678 million, an increase of 21.8% over Q3 last year. For the first nine months, API sales were ₹15,962 million, growing by 6.2%. The API portfolio continues to support both the formulation business and customers globally.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 6, 2025, 8:03 AM IST
Sachin Gupta
Sachin Gupta is a Content Writer with 6+ years of experience in the stock market, including global markets like the US, Canada, and Australia. At Angel One, Sachin specialises in creating financial content that simplifies complex market trends. Sachin holds a Master's in Commerce, specialising in Economics.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
